Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1981 1
1992 3
1995 1
2003 1
2007 1
2010 1
2013 2
2018 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Fatal hepatitis during Epstein-Barr virus reactivation.
Cacopardo B, Nunnari G, Mughini MT, Tosto S, Benanti F, Nigro L. Cacopardo B, et al. Among authors: mughini mt. Eur Rev Med Pharmacol Sci. 2003 Jul-Aug;7(4):107-9. Eur Rev Med Pharmacol Sci. 2003. PMID: 15068233
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial.
Fabbiani M, Gagliardini R, Ciccarelli N, Quiros Roldan E, Latini A, d'Ettorre G, Antinori A, Castagna A, Orofino G, Francisci D, Chinello P, Madeddu G, Grima P, Rusconi S, Del Pin B, Lombardi F, D'Avino A, Focà E, Colafigli M, Cauda R, Di Giambenedetto S, De Luca A; ATLAS-M Study Group. Fabbiani M, et al. J Antimicrob Chemother. 2018 Jul 1;73(7):1955-1964. doi: 10.1093/jac/dky123. J Antimicrob Chemother. 2018. PMID: 29668978 Clinical Trial.
Systemic inflammation markers after simplification to atazanavir/ritonavir plus lamivudine in virologically suppressed HIV-1-infected patients: ATLAS-M substudy.
Belmonti S, Lombardi F, Quiros-Roldan E, Latini A, Castagna A, Borghetti A, Baldin G, Ciccullo A, Cauda R, De Luca A, Di Giambenedetto S; ATLAS-M Study Group. Belmonti S, et al. J Antimicrob Chemother. 2018 Jul 1;73(7):1949-1954. doi: 10.1093/jac/dky125. J Antimicrob Chemother. 2018. PMID: 29788156 Clinical Trial.
High prevalence of undiagnosed anxiety symptoms among HIV-positive individuals on cART: a cross-sectional study.
Celesia BM, Nigro L, Pinzone MR, Coco C, La Rosa R, Bisicchia F, Mavilla S, Gussio M, Pellicanò G, Milioni V, Palermo F, Russo R, Mughini MT, Martellotta F, Taibi R, Cacopardo B, Nunnari G. Celesia BM, et al. Among authors: mughini mt. Eur Rev Med Pharmacol Sci. 2013;17(15):2040-6. Eur Rev Med Pharmacol Sci. 2013. PMID: 23884824 Free article.
HCV and HIV infection among intravenous drug abusers in eastern Sicily.
Cacopardo B, Fatuzzo F, Cosentino S, Celesia BM, Mughini MT, La Rosa R, Bruno S, Lupo G, Zipper F, La Medica G, et al. Cacopardo B, et al. Among authors: mughini mt. Arch Virol Suppl. 1992;4:333-4. doi: 10.1007/978-3-7091-5633-9_77. Arch Virol Suppl. 1992. PMID: 1450715
14 results